Relapse pathway of glioblastoma revealed by single-cell molecular analysis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Carcinogenesis

• Publication date

  2018-07-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/carcin/bgy052PMID 29718126PMCID PMC6248540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lomustine and Bevacizumab in Progressive Glioblastoma

  2017cited by this paper
• Spatiotemporal genomic architecture informs precision oncology in glioblastoma

  2017cited by this paper
• Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq

  2017cited by this paper
• Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma.

  2016cited by this paper
• The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

  2016cited by this paper
• Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity

  2015cited by this paper
• RasGRP3 regulates the migration of glioma cells via interaction with Arp3

  2015cited by this paper
• Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis

  2014cited by this paper
• Cancer genomic research at the crossroads: realizing the changing genetic landscape as intratumoral spatial and temporal heterogeneity becomes a confounding factor

  2014cited by this paper
• α-Catulin drives metastasis by activating ILK and driving an αvβ3 integrin signaling axis.

  2013cited by this paper
• α-Catulin Marks the Invasion Front of Squamous Cell Carcinoma and Is Important for Tumor Cell Metastasis

  2012cited by this paper
• Highly Parallel Genome-Wide Expression Analysis of Single Mammalian Cells

  2012cited by this paper
• GENCODE: The reference human genome annotation for The ENCODE Project

  2012cited by this paper
• Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

  2012cited by this paper
• Cancer stem cells from a rare form of glioblastoma multiforme involving the neurogenic ventricular wall

  2012cited by this paper
• Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity

  2012cited by this paper
• Increase developmental plasticity of human keratinocytes with gene suppression

  2011cited by this paper
• A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data

  2011cited by this paper
• A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Initially Mimicking Cutaneous Lupus Erythematosus

  2010influential reference
• Early endosome localization and activity of RasGEF1b, a toll-like receptor-inducible Ras guanine-nucleotide exchange factor

  2010cited by this paper
• Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.

  2010cited by this paper
• Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

  2010cited by this paper
• α-Catulin, a Rho signalling component, can regulate NF-κB through binding to IKK-β, and confers resistance to apoptosis

  2008cited by this paper
• A microfluidic processor for gene expression profiling of single human embryonic stem cells.

  2008cited by this paper
• Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.

  2008cited by this paper
• Alpha-catulin, a Rho signalling component, can regulate NF-kappaB through binding to IKK-beta, and confers resistance to apoptosis.

  2008cited by this paper
• Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma

  2007cited by this paper
• A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery

  2007cited by this paper
• Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain.

  2006influential reference
• Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas.

  2005cited by this paper
• Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.

  2005influential reference
• Distinct Activities of the α-Catenin Family, α-Catulin and α-Catenin, on β-Catenin-Mediated Signaling

  2004cited by this paper
• Gene Expression Profiling of Gliomas Strongly Predicts Survival

  2004cited by this paper
• Gene expression profiling identifies molecular subtypes of gliomas

  2003cited by this paper
• Association of Lbc Rho Guanine Nucleotide Exchange Factor with α-Catenin-related Protein, α-Catulin/CTNNAL1, Supports Serum Response Factor Activation*

  2002cited by this paper
• Association of Lbc Rho guanine nucleotide exchange factor with alpha-catenin-related protein, alpha-catulin/CTNNAL1, supports serum response factor activation.

  2002cited by this paper
• The Book of Prescriptions

  1926cited by this paper
• A Classification of the Tumours of the Glioma Group on a Histogenetic Basis With a Correlated Study of Prognosis

  1926cited by this paper

• Rethinking p16, p53, and HPV in HNCSCC through lessons from glioblastoma subclonal evolution toward patient-centric N-of-1 single-cell RNA sequencing paradigm

  2025cites this paper
• A spatial transcriptomics study of MES-like and mono/macro cells in gliomas

  2025cites this paper
• Therapeutic and prognostic values of ferroptosis signature in glioblastoma.

  2025cites this paper
• Biomarker-Guided Dynamic Liquid Biopsy System for Enhanced Detection of Glioblastoma Recurrence via Blood–Brain Barrier Permeability Optimisation

  2025cites this paper
• Machine Learning for Detecting and Analyzing Chromoanagenesis Events.

  2025cites this paper
• Next-Generation Sequencing: A Review of Its Transformative Impact on Cancer Diagnosis, Treatment, and Resistance Management

  2025cites this paper
• Research progress of single cell RNA sequencing in nervous system

  2025cites this paper
• Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data

  2023cites this paper
• Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?

  2022cites this paper
• FMRP modulates the Wnt signalling pathway in glioblastoma

  2022cites this paper
• Estimating intraclonal heterogeneity and subpopulation changes from bulk expression profiles in CMap

  2022cites this paper
• Phase I Study of High-Dose l-Methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH Wild-Type High-Grade Glioma

  2022cites this paper
• Cytokine chemokine network in tumor microenvironment: Impact on CSC properties and therapeutic applications.

  2022cites this paper
• Chromoanagenesis Landscape in 10,000 TCGA Patients

  2021cites this paper
• What are the applications of single-cell RNA sequencing in cancer research: a systematic review

  2021cites this paper
• Evidence for AJUBA-catenin-CDH4-linked differentiation resistance of mesenchymal stem cells implies tumorigenesis and progression of head and neck squamous cell carcinoma: a single-cell transcriptome approach.

  2021cites this paper
• Estimating Intraclonal Heterogeneity and Subpopulation Changes from Perturbational Bulk Gene Expression Profiles in LINCS L1000 CMap by Premnas

  2021cites this paper
• Pilocytic Astrocytoma-Derived Cells in Peripheral Blood: A Case Report

  2021cites this paper
• Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial

  2021cites this paper
• Combination with Temozolomide and Bevacizumab in Recurrent IDH Wild-Type High-Grade Glioma

  2021cites this paper
• Glioblastoma-initiating cell heterogeneity generated by the cell-of-origin, genetic/epigenetic mutation and microenvironment.

  2021cites this paper
• Embryonic Origin and Subclonal Evolution of Tumor-Associated Macrophages Imply Preventive Care for Cancer

  2021cites this paper
• Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas

  2020cites this paper
• Hunting down the dominating subclone of cancer stem cells as a potential new therapeutic target in multiple myeloma: An artificial intelligence perspective

  2020cites this paper
• Tumor edge-to-core transition promotes malignancy in primary-to-recurrent glioblastoma progression in a PLAGL1/CD109-mediated mechanism

  2020cites this paper
• Discovery of peculiar cells in the peri-tumoral regions and peripheral blood of glioblastoma patients by single cell RNA-sequencing

  2020cites this paper
• Genetic characterization of stem cell-like cancer cell in the peri-tumoral regions and proliferative lymphocyte in the peripheral blood of patients with glioblastoma

  2020cites this paper
• "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing.

  2020cites this paper
• Recent Advances in Cancer Stem Cell-Targeted Immunotherapy

  2019cites this paper
• Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.

  2019cites this paper
• Longitudinal Characteristics of Glioblastoma in Genome-Wide Studies

  2019cites this paper
• Genetic Hallmarks and Heterogeneity of Glioblastoma in the Single‐Cell Omics Era

  2019cites this paper
• Use of chimeric antigen receptor T cells in allogeneic hematopoietic stem cell transplantation.

  2019cites this paper
• Cancer Subclones Derived from the Patient’s Head and Neck Squamous Cell Carcinoma Tumor Stem Cells for the Screening of Personalized Antitumor Immunotherapy and Chemotherapy

  2018cites this paper
• World Journal of Stem Cells

  year unknowncites this paper